References

1. ROSENFIELD RE et al. Problems in Rh typing as revealed by a single Negro family. Am J Hum Genet, 1960. [Citation] [RHeference]
2. Salmon C et al. [The gene complex DIV (C)-]. Rev Fr Transfus, 1969. [Citation] [RHeference]
3. Lewis M et al. Assignment of the red cell antigen, Targett (Rh40), to the Rh blood group system. Am J Hum Genet, 1979. [Citation] [RHeference]
4. Leader KA et al. Human monoclonal anti-D with reactivity against category DVI cells used in blood grouping and determination of the incidence of the category DVI phenotype in the DU population. Vox Sang, 1990. [Citation] [RHeference]
5. López López C et al. [Testicular torsion. The first manifestation of polyorchidism]. Actas Urol Esp, 1992. [Citation] [RHeference]
6. Arce MA et al. Molecular cloning of RhD cDNA derived from a gene present in RhD-positive, but not RhD-negative individuals. Blood, 1993. [Citation] [RHeference]
7. Mouro I et al. Rearrangements of the blood group RhD gene associated with the DVI category phenotype. Blood, 1994. [Citation] [RHeference]
8. Wagner F et al. [Occurrence of D category VI in blood donors in Baden-Württemberg]. Beitr Infusionsther Transfusionsmed, 1994. [Citation] [RHeference]
9. Armstrong-Fisher SS et al. Molecular analysis of DVI variant ISBT 35 (R2VIr). Transfus Clin Biol, 1996. [Citation] [RHeference]
10. Avent ND et al. Evidence of genetic diversity underlying Rh D-, weak D (Du), and partial D phenotypes as determined by multiplex polymerase chain reaction analysis of the RHD gene. Blood, 1997. [Citation] [RHeference]
11. Legler TJ et al. D(Va) category phenotype and genotype in Japanese families. Vox Sang, 2000. [Citation] [RHeference]
12. Esteban R et al. RhD epitope expression in a RHD negative individual: characterization of a novel RHCE variant allele. Transfusion Clinique et Biologique, 2001. — Abstract — [RHeference]
13. Müller TH et al. PCR screening for common weak D types shows different distributions in three Central European populations. Transfusion, 2001. [Citation] [RHeference]
14. Kamesaki T et al. Molecular characterization of weak D phenotypes by site-directed mutagenesis and expression of mutant Rh-green fluorescence protein fusions in K562 cells. Vox Sang, 2001. [Citation] [RHeference]
15. Omi T et al. Isolation, characterization, and family study of DTI, a novel partial D phenotype affecting the fourth external loop of D polypeptides. Transfusion, 2002. [Citation] [RHeference]
16. Noizat-Pirenne F et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood, 2002. [Citation] [RHeference]
17. Wagner FF et al. RHD allele distribution in Africans of Mali. BMC Genet, 2003. [Citation] [RHeference]
18. Kamesaki T et al. A novel mutation in the RHD gene in Japanese individuals with weak D, encoding an amino acid change in the 11th transmembranous domain of the RhD protein. Vox Sang, 2003. [Citation] [RHeference]
19. Körmöczi GF et al. Molecular and serologic characterization of DWI, a novel "high-grade" partial D. Transfusion, 2004. [Citation] [RHeference]
20. Doescher A et al. Weak D type 1.1 exemplifies another complexity in weak D genotyping. Transfusion, 2005. [Citation] [RHeference]
21. Flegel WA et al. In-frame triplet deletions in RHD alter the D antigen phenotype. Transfusion, 2006. [Citation] [RHeference]
22. Esteban R et al. The D category VI type 4 allele is prevalent in the Spanish population. Transfusion, 2006. [Citation] [RHeference]
23. Nogues N et al. RHD null alleles in the Spanish population Vox Sanguinis, 2007. — Abstract — [RHeference]
24. MP Martinez Badas et al. Anti-D immunization in a D-positive mother Vox Sanguinis, 2007. — Abstract — [RHeference]
25. Müller SP et al. The determination of the fetal D status from maternal plasma for decision making on Rh prophylaxis is feasible. Transfusion, 2008. [Citation] [RHeference]
26. Touinssi M et al. Molecular analysis of inactive and active RHD alleles in native Congolese cohorts. Transfusion, 2009. [Citation] [RHeference]
27. Hua X et al. A new RHD-positive, D antigen negative allele in Chinese. Vox Sang, 2010. [Citation] [RHeference]
28. Silvy M et al. Weak D and DEL alleles detected by routine SNaPshot genotyping: identification of four novel RHD alleles. Transfusion, 2011. [Citation] [RHeference]
29. D. Bruce et al. Immune Alloanti-D in a Patient With Weak D Type 33 Genotype Transfusion Medicine, 2011. — Abstract — [RHeference]
30. Dogic V et al. Distribution of weak D types in the Croatian population. Transfus Med, 2011. [Citation] [RHeference]
31. Moussa H et al. Molecular background of D-negative phenotype in the Tunisian population. Transfus Med, 2012. [Citation] [RHeference]
32. Szulman A et al. Investigation of pseudogenes RHDΨ and RHD-CE-D hybrid gene in D-negative blood donors by the real time PCR method. Transfus Apher Sci, 2012. [Citation] [RHeference]
33. Fichou Y et al. Weak D caused by a founder deletion in the RHD gene. Transfusion, 2012. [Citation] [RHeference]
34. Silvy M et al. Characterization of novel RHD alleles: relationship between phenotype, genotype, and trimeric architecture. Transfusion, 2012. [Citation] [RHeference]
35. Cruz BR et al. RHD alleles in Brazilian blood donors with weak D or D-negative phenotypes. Transfus Med, 2012. [Citation] [RHeference]
36. Silvy M et al. Identification of novel polymorphism restricted to the (C)ces type 1 haplotype avoids risk of transfusion deadlock in SCD patients. Br J Haematol, 2013. [Citation] [RHeference]
37. Granier T et al. A comprehensive survey of both RHD and RHCE allele frequencies in sub-Saharan Africa. Transfusion, 2013. [Citation] [RHeference]
38. Arnoni CP et al. How do we identify RHD variants using a practical molecular approach? Transfusion, 2014. [Citation] [RHeference]
39. Gowland P et al. Molecular RHD screening of RhD negative donors can replace standard serological testing for RhD negative donors. Transfus Apher Sci, 2014. [Citation] [RHeference]
40. Costa S et al. RHD alleles and D antigen density among serologically D- C+ Brazilian blood donors. Transfus Med, 2014. [Citation] [RHeference]
41. Costa SSM et al. Management of Blood Transfusion in a Patient Carrying Anti-Rh18 Associated with the RHD*Weak D 4.2.2/RHCE*ceAR Haplotype Blood Disorders & Transfusion, 2015. — Article — [RHeference]
42. Kacem N et al. Paternal RHD zygosity determination in Tunisians: evaluation of three molecular tests. Blood Transfus, 2015. [Citation] [RHeference]
43. Ba A et al. RH diversity in Mali: characterization of a new haplotype RHD*DIVa/RHCE*ceTI(D2). Transfusion, 2015. [Citation] [RHeference]
44. Lopez GH et al. A D+ blood donor with a novel RHD*D-CE(5-6)-D gene variant exhibits the low-frequency antigen RH23 (D(W) ) characteristic of the partial DVa phenotype. Transfusion, 2016. [Citation] [RHeference]
45. Clarke G et al. Resolving variable maternal D typing using serology and genotyping in selected prenatal patients. Transfusion, 2016. [Citation] [RHeference]
46. Yazer MH et al. Low incidence of D alloimmunization among patients with a serologic weak D phenotype after D+ transfusion. Transfusion, 2016. [Citation] [RHeference]
47. Costa SS et al. RHD*weak D type 38: a family study. Rev Bras Hematol Hemoter, 2016. [Citation] [RHeference]
48. Filosa L et al. New silent and weak D alleles: molecular characterization and associated antigen density. Transfusion, 2016. [Citation] [RHeference]
49. El Wafi M et al. Novel intronic RHD variants identified in serologically D-negative blood donors. Vox Sang, 2017. [Citation] [RHeference]
50. Granier T et al. First description of a D-CE-D hybrid gene on a weak D Type 2 molecular background. Transfusion, 2017. [Citation] [RHeference]
51. Floch A et al. Molecular characterization of 13 new RHD alleles. Transfusion, 2017. [Citation] [RHeference]
52. Jérôme Babinet et al. Inscription des individus RH : −1, −4 ou RH : −1, −5 dans le registre national de référence des sujets présentant un phénotype/génotype érythrocytaire rare : intérêt de la réalisation d’une PCR multiplexe systématique pour le dépistage des variants RH1 affaiblis non détectés par sérologie de routine Transfusion Clinique et Biologique, 2017. — Abstract — [RHeference]
53. Chou ST et al. Whole-exome sequencing for RH genotyping and alloimmunization risk in children with sickle cell anemia. Blood Adv, 2017. [Citation] [RHeference]
54. Saleheen D et al. Human knockouts and phenotypic analysis in a cohort with a high rate of consanguinity. Nature, 2017. [Citation] [RHeference]
55. V L. Thonier et al. Complex Antibody Mixture in a Pregnant Woman Harboring the RHD*DIIIb Variant Allele Transfusion, 2018. — Abstract — [RHeference]
56. J S. Woo et al. Robust Allo-Anti-D with Subsequent Anti-K Production after Transfusion of D-Positive RBCs to a Patient with Weak D Type 1 Transfusion, 2018. — Abstract — [RHeference]
57. Jérôme Babinet et al. Erratum à l’article : « Résumés des Posters » [Transfus. Clin. Biol. 24 (2017) 3S] Transfusion Clinique et Biologique, 2018. — Abstract — [RHeference]
58. de Brevern AG et al. Alloimmunization risk associated with amino acid 223 substitution in the RhD protein: analysis in the light of molecular modeling. Transfusion, 2018. [Citation] [RHeference]
59. Qian C et al. A new RhD variant allele is caused by a RhD 26 T > G mutation in a Chinese Han woman with a weak D phenotype. Transfusion, 2019. [Citation] [RHeference]
60. Izaskun Apraiz et al. Performance Evaluation Study of ID RHD XT as a Molecular Tool for RHD Gene Screening in Pooled Blood Samples of Serologically D− C/E+ Donors Transfusion, 2019. — Abstract — [RHeference]
61. Matzhold EM et al. RHD del28Phe (DMW) encoded by a novel in-frame deletion resulting in reduced D antigen expression. Transfusion, 2019. [Citation] [RHeference]
62. Sunitha Vege et al. Novel RHD Alleles Identified When Resolving Serologic Weak D Phenotypes Transfusion, 2019. — Abstract — [RHeference]
63. Takeuchi-Baba C et al. Production of RBC autoantibody mimicking anti-D specificity following transfusion in a patient with weak D Type 15. Transfusion, 2019. [Citation] [RHeference]
64. Trucco Boggione C et al. Characterization of RHD locus polymorphism in D negative and D variant donors from Northwestern Argentina. Transfusion, 2019. [Citation] [RHeference]
65. El Housse H et al. Comprehensive phenotypic and molecular investigation of RhD and RhCE variants in Moroccan blood donors. Blood Transfus, 2019. [Citation] [RHeference]
66. Aline Floch et al. Understanding anti-D formation in RhD variants through the study of 3D intraprotein interactions manuscript in preparation, 2020. — Article — [RHeference]
67. Safic Stanic H et al. D variants in the population of D-negative blood donors in the north-eastern region of Croatia. Transfus Med, 2021. [Citation] [RHeference]